2009
DOI: 10.5551/jat.e471
|View full text |Cite
|
Sign up to set email alerts
|

Association of Polymorphism of Estrogen Receptor-.ALPHA. Gene with Circulating Levels of Adiponectin in Postmenopausal Women with Type 2 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 41 publications
(36 reference statements)
1
14
0
1
Order By: Relevance
“…Human inactivating mutations in the estrogen receptor (ER) α isotype recapitulate aspects of the metabolic syndrome (11)(12)(13)(14), and diminished ERα expression is associated with obesity in women (15). Indeed, rodents harboring a homozygous Esr1 null mutation display glucose intolerance, heightened tissue inflammation, insulin resistance, and marked obesity (16)(17)(18).…”
mentioning
confidence: 99%
“…Human inactivating mutations in the estrogen receptor (ER) α isotype recapitulate aspects of the metabolic syndrome (11)(12)(13)(14), and diminished ERα expression is associated with obesity in women (15). Indeed, rodents harboring a homozygous Esr1 null mutation display glucose intolerance, heightened tissue inflammation, insulin resistance, and marked obesity (16)(17)(18).…”
mentioning
confidence: 99%
“…The T allele of PvuII was associated with low serum levels of adiponectin, which might lead to a high risk of CVD in postmenopausal women. 41 Moreover, Hayashi et al 42 reported that only women with a TT genotype had increased arterial stiffness, whereas men did not. Ferrero et al 43 reported that women homozygous for the T allele treated with coronary stent implantation had a higher risk of in-stent restenosis than did men.…”
Section: Discussionmentioning
confidence: 99%
“…Thirdly, genetic factors were not included in this study. Genetic variation in the action of estrogen plays a role in regulating circulating levels of adiponectin 46) , which may influence the change of CRF because of menopause. Further studies are needed to identify women at high risk after menopause due to genetic factors.…”
Section: Discussionmentioning
confidence: 99%